Unveiling a novel disulfide-mediated prognostic classification and immune landscape in lung adenocarcinoma: Implications for therapeutic interventions. (PubMed, Comput Biol Chem) - Oct 11, 2026 - "DRLC genes play vital roles in LUAD development, progression, immune microenvironment, and patient survival. We developed Cox regression models based on 28 key DRLC genes for survival prediction, which were internally consistent, pending external validation. Furthermore, potential drugs were suggested to be effective in LUAD when used in conjunction with disulfidptosis strategies."
Journal • Lung Adenocarcinoma • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • SLC7A11
|